D-0321-2024 Class III Ongoing

Recalled by Teva Pharmaceuticals USA, Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
February 21, 2024
Initiation Date
January 25, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12,916 cartons

Product Description

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67

Reason for Recall

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

Distribution Pattern

nationwide

Code Information

Lot #: 100042978, Exp 7/31/2024